The Italian Patent and Trademark Office has officially recognized the patent for the REMAST® therapy
The positive evaluation of the Italian Patent and Trademark Office led to the expected recognition for the REMaST® therapy two years after the submission of the application, marking a significant step in our development path.
The patent concerns the cell therapy product REMaST® , the method developed by Hemera to obtain it and its use in tissue regeneration. This result marks a great achievement for the company and for the entire R&D team led by Prof. Ilaria Decimo.
We are grateful to all those who have supported us during this first phase of growth and we recognize the importance of strategic partnerships in achieving common goals.
Hemera continues to develop and protect its scientific and technological know-how, investing in research and innovation.